These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32938851)

  • 1. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
    Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.
    Ishigaki S; Ohashi N; Isobe S; Tsuji N; Iwakura T; Ono M; Sakao Y; Tsuji T; Kato A; Miyajima H; Yasuda H
    Clin Exp Nephrol; 2016 Dec; 20(6):878-884. PubMed ID: 26743744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
    Ohashi N; Aoki T; Matsuyama T; Ishigaki S; Isobe S; Katahashi N; Sato T; Fujikura T; Kato A; Yasuda H
    Intern Med; 2020 Feb; 59(3):357-364. PubMed ID: 31534091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
    Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors.
    Ohashi N; Isobe S; Matsuyama T; Ishigaki S; Suzuki T; Tsuji T; Otsuka A; Kato A; Miyake H; Yasuda H
    Intern Med; 2019 Mar; 58(5):643-648. PubMed ID: 30333423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.
    Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H
    Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage.
    Isobe S; Ohashi N; Fujikura T; Tsuji T; Sakao Y; Yasuda H; Kato A; Miyajima H; Fujigaki Y
    Clin Exp Nephrol; 2015 Apr; 19(2):231-9. PubMed ID: 24728489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
    Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
    Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased heart rate is associated with intrarenal renin-angiotensin system activation in chronic kidney disease patients.
    Ohashi N; Isobe S; Ishigaki S; Aoki T; Matsuyama T; Sato T; Fujikura T; Kato A; Yasuda H
    Clin Exp Nephrol; 2019 Sep; 23(9):1109-1118. PubMed ID: 31131423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients.
    Ohashi N; Isobe S; Matsuyama T; Ishigaki S; Tsuji N; Fujikura T; Tsuji T; Kato A; Yasuda H
    Hypertens Res; 2018 May; 41(5):334-341. PubMed ID: 29507351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
    Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
    Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
    Xu Z; Xu B; Xu C
    Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Urinary Angiotensinogen Excretion Predicts Deterioration of the Kidney Function in Patients with Chronic Kidney Disease.
    Ishigaki S; Ohashi N; Aoki T; Matsuyama T; Isobe S; Sato T; Fujikura T; Kato A; Yasuda H
    Intern Med; 2021 Jul; 60(14):2201-2206. PubMed ID: 33612680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight.
    Yamamura-Miyazaki N; Michigami T; Satomura K; Urushihara M; Kagami S; Yamamoto K
    Pediatr Nephrol; 2020 Jul; 35(7):1307-1314. PubMed ID: 32162100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney.
    Ohashi N; Isobe S; Ishigaki S; Yasuda H
    Hypertens Res; 2017 May; 40(5):413-422. PubMed ID: 27904154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pivotal role of melatonin in ameliorating chronic kidney disease by suppression of the renin-angiotensin system in the kidney.
    Ohashi N; Ishigaki S; Isobe S
    Hypertens Res; 2019 Jun; 42(6):761-768. PubMed ID: 30610209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
    Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
    J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
    Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
    Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.